Logo

Innovative Drugs to Restore Neurological Function

Search Btn
  • Home
  • About Us
    • About Us
    • Management
    • Scientific Advisory Board
    • Board of Advisors
  • Disease Focus
    • Technology
    • Spinal Cord Injury
    • Cerebral Vascular Disorder
  • Patients
    • Patients
  • News
  • Contact Us
    • Contact Us

Ron Goldstein Picture

News

Jan 9, 2023: Cerebral Cavernous Malformation Drug licensed to Neurelis now a clinical stage drug. Click here for the full story.
June 20, 2022: BioAxone BioSciences Announces Patent Issued for Pharmaceutical Compositions of BA-210 for treatment of spinal cord injury Click here for the full story .
Aug 28 2020: BioAxone Announces License of Cerebral Cavernous Malformation Drug to to Neurelis. Click here for the full story.

Events

Upcoming scientific conferences on spinal cord injury Click here to access site .
Information on cerebral cavernous malformation Click here to access site .

© 2024 BioAxone | 90 Canal Street, 4th Floor | Boston, MA 02114 | Ph: 617-401-3115 | Site by KWWD.co